Anifrolumab, a relatively emerging monoclonal protein, is generating considerable excitement within the healthcare community as a possible solution for various autoimmune conditions. This unique agent targets the https://gerardrexu086576.blognody.com/49851635/anifrolumab-a-new-approach-for-autoimmune-illnesses